SCHEMBL16798257

SCHEMBL16798257

COC(=O)CC(Cc1ccc(Cl)cc1)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.62
▸ PPARG P37231 4/20 0.52
▸ EPHX2 P34913 1/20 0.52
▸ MEN1 O00255 2/20 0.49
▸ PPARA Q07869 4/20 0.49
▸ BCL2L1 Q07817 1/20 0.48
▸ MCL1 Q07820 1/20 0.48
▸ FDFT1 P37268 1/20 0.48
▸ CPA1 P15085 2/20 0.47
▸ CPB1 P15086 1/20 0.47
▸ CPA3 P15088 1/20 0.47
▸ CPB2 Q96IY4 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16798274 0.88 KMT2A (0.49) KMT2APPARGEPHX2MEN1PPARA
SCHEMBL7505398 0.85 CPA1 (0.66) CPA1CPB1CPA3CPB2CYP1A2
SCHEMBL9574107 0.85 CPA1 (0.66) CPA1CPB1CPA3CPB2CYP1A2
SCHEMBL16798223 0.84 CPA1 (0.47) KMT2APPARGEPHX2PPARACPA1
SCHEMBL4504708 0.84 KMT2A (0.52) KMT2APPARGEPHX2MEN1PPARA
SCHEMBL1915429 0.84 KMT2A (0.52) KMT2APPARGEPHX2MEN1PPARA
SCHEMBL1915428 0.84 KMT2A (0.52) KMT2APPARGEPHX2MEN1PPARA
SCHEMBL11463940 0.82 KMT2A (0.46) KMT2APPARGMEN1PPARAALDH1A1
SCHEMBL28074267 0.82 CPA1 (0.70) KMT2APPARGEPHX2MEN1PPARA
SCHEMBL4663230 0.81 CYP1A2 (0.65) KMT2APPARGEPHX2PPARABCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3077401-A1 SERINE/THREONINE KINASE INHIBITORS Genentech, Inc. (US) 2016-10-12 — — EP disclosed
WO-2015085007-A1 SERINE/THREONINE KINASE INHIBITORS GENENTECH, INC. (US) 2015-06-11 — — WO disclosed
Send feedback